HomeInsights52 Week High Stocks

Kabra Drugs Ltd 52 Week High

Kabra Drugs Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 9, 2024)

stocks purchased

2.4 K

Stocks Traded

(Dec 9, 2024)

Last Updated on: Dec 12, 2024

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

YEARHIGH

₹ 9.59

Last updated on: Dec 09, 2024

Key Highlights

  • The 52 Week HIGH of Kabra Drugs Ltd is ₹ 9.59 as of 09 Dec 24 .

Company Fundamentals for Kabra Drugs Ltd

No data available

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Dec 20249.59
02 Dec 20249.59
25 Nov 20249.59
18 Nov 20249.59
11 Nov 20249.59
04 Nov 20249.14
28 Oct 20249.14
21 Oct 20249.14
14 Oct 20249.14
07 Oct 20249.14

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Kabra Drugs Ltd News Hub

News

Kabra Drugs to conduct EGM

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be ...

Read more

05 Dec 2024 17:27

News

Kabra Drugs schedules board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 202...

Read more

26 Nov 2024 09:56

News

Kabra Drugs to convene board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 20...

Read more

08 Nov 2024 12:27

News

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 202...

Read more

22 Oct 2024 11:01

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 2024 09:56

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 20...

Read more

28 Aug 2024 14:54

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Kabra Drugs Ltd

What is the significance of Kabra Drugs Ltd reaching its 52-week high?

Kabra Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Kabra Drugs Ltd 52-week high?

Investors monitor Kabra Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Kabra Drugs Ltd a good buy when it hits its 52-week high?

Whether Kabra Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Kabra Drugs Ltd fundamentals.

What should I consider before investing in Kabra Drugs Ltd at its 52-week high?

Before investing in Kabra Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Kabra Drugs Ltd stock price continue to rise after reaching its 52-week high?

Kabra Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions